SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095427
Filing Date
2024-08-12
Accepted
2024-08-12 16:11:03
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crgx-20240630.htm   iXBRL 10-Q 2439850
2 EX-10.2 crgx-ex10_2.htm EX-10.2 28584
3 EX-10.3 crgx-ex10_3.htm EX-10.3 31882
4 EX-31.1 crgx-ex31_1.htm EX-31.1 13251
5 EX-31.2 crgx-ex31_2.htm EX-31.2 13031
6 EX-32.1 crgx-ex32_1.htm EX-32.1 12270
7 GRAPHIC img27997552_0.jpg GRAPHIC 60247
  Complete submission text file 0000950170-24-095427.txt   9000366

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crgx-20240630.xsd EX-101.SCH 1518898
72 EXTRACTED XBRL INSTANCE DOCUMENT crgx-20240630_htm.xml XML 1183949
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

IRS No.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41859 | Film No.: 241196871
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)